A diagnostic study on the detection of occlusal caries from a clinical photograph using a deep learning algorithm will be presented at the 101st General
Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to
Australian and international experts have released 11 recommendations on when, how, and in what situation it may be appropriate for clinicians to reduce opioid use,
Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention. Basking in the
Monthly cash payments to eligible families under the temporary pandemic-era expansion of the federal Child Tax Credit led to better adult health and food security,
SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an
Welcome to our latest TDR Psychedelics Exclusive. We’re on location in Denver, CO at the MAPS conference. This podcast, we’re sitting with the founder and
Eli Lilly’s tirzepatide is still the most effective weight-loss treatment to date, according to detailed data from its Phase III SURMOUNT-2 study released at the
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit
SAN DIEGO — Orforglipron, an investigational nonpeptide GLP-1 receptor agonist, helped people with obesity lose a significant amount of weight in a phase II trial.